Back

Bone marrow S-phase is Associated with Risk assessment and Shows Differential Correlation with levels of CD34+ Blasts and CD16- Granulocytes in Patients with Myelodysplastic syndromes

2024-06-07 hematology Title + abstract only
View on medRxiv
Show abstract

IntroductionIncluding of proliferative parameters in the routine clinical flow-cytometry (FC) workup may be important for better evaluation of prognosis and risk assessment in patients with myelodysplastic syndromes (MDS). However, supportive data are still contradicting. AimTo assess the levels of FC based proliferative parameters in patients with MDS using propidium Iodide, and to study their correlation with risk assessment and the incidences of CD34+ blasts and CD16- and CD16+ granulocytes....

Predicted journal destinations